Search for: "Martin et al v. Impact Health"
Results 21 - 36
of 36
Sort by Relevance
|
Sort by Date
1 Jun 2011, 4:05 pm
Int’l L. 457-550 (2010).Carrico, Amanda R., et al. [read post]
17 May 2011, 7:23 am
Ware, et al., “Statistics in Medicine — Reporting of Subgroup Analyses in Clinical Trials,” 357 New Engl. [read post]
16 Feb 2011, 2:16 pm
News & Analysis 11111-11114 (2010).Batker, David, et al. [read post]
28 Jan 2011, 1:04 pm
[et al.]. [read post]
15 Nov 2010, 11:44 am
Hildreth, et al. 27 Pace Envtl. [read post]
14 Oct 2010, 11:58 am
L. 357-398 (2010).Vandenbergh, Michael P., et al. [read post]
1 Oct 2010, 5:18 pm
11(1) JOURNAL OF HUMAN DEVELOPMENT & CAPABILITIES 67-84 (2010) Martin Karlsson, et al. [read post]
2 Aug 2010, 11:15 am
“To protect public health and the environment, we will vigilantly track down violators and bring them into compliance. [read post]
26 Jul 2010, 9:08 am
Alcoa Inc., et al, Civil No. 2:10-cv-05051-GW (PLAx) (C.D. [read post]
19 Jul 2010, 3:37 pm
Environmental Protection Agency, state Department of Health and three environmental groups. [read post]
5 Jul 2010, 7:59 pm
Brown and David Matusow, Bahr, et al. v. [read post]
13 Apr 2010, 9:45 am
Having passed both chambers, the Maryland False Health Claims Act of 2010 (“MFHCA”) has just been signed by Governor Martin O’Malley and will be effective October 1, 2010. [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge), (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v Apotex:… [read post]
10 Mar 2008, 1:10 pm
MASON et al. v. [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners:… [read post]
1 Mar 2007, 4:57 am
OCs (Estimated Relative Risk or Odds Ratio with 95% CI) Bloemenkamp et al,[8]1995 Case-Control 2.2 (0.9-5.4) Spitzer (Transnational),[9] 1996 Case-Control 1.5 (1.1-2.2) Bloemankamp et al,[13] 1999 Case-Control 1.9 (0.8-4.5) Jick et al (UK-GPRD),[14] 2000 Cohort/Case-Control 1.9 (1.3-2.8)/2.3 (1.3-3.9) Farley et al (WHO),[6] 1995 Case-Control 2.4 (1.3-4.6) Jick et al (UK-GPRD),[7] 1995 Cohort/Case-Control 1.9… [read post]
